Medical Coating Market worth $15,813.6 million by 2030 - Exclusive Report by MarketsandMarkets™
Factors contributing to the medical coating market include the rising prevalence of chronic diseases, increased demand for advanced medical devices, and a growing geriatric population. Other factors driving the adoption and innovation of medical coatings include improved infection control, the growth of minimally invasive procedures, and shorter trial studies related to regulatory requirements for biocompatibility.
Browse in-depth TOC on "Medical Coating Market"
300 - Tables 50 - Figures 179 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76047356
Metals will account for the second-largest share in the medical coating market by material during the forecast period, in terms of value.
Metals are expected to hold the second-largest share of the medical coating market, by material, during the forecast period, in terms of value. Metals possess key attributes such as strength, combined with advantageous biocompatibility and durability, making them ideal for high-performance medical devices like orthopaedic implants and cardiovascular stents. Metals like silver and titanium have unique antimicrobial properties that help reduce infection risk inherently when used in implants and bearings. The growth in demand for metal coatings during this period is driven by advances in surface modification technologies and an increasing need for infection control within healthcare organizations.
Medical implants will be the second-fastest-growing application in the medical coating market during the forecast period, in terms of value.
During the forecast period, medical implants are the second fastest-growing application in the medical coating market in terms of value, mainly due to the rising prevalence of chronic diseases and the rapidly aging global population. Advances in biomaterials and coating technologies are also making implants safer and more durable with improved biocompatibility. In addition to these safety improvements, the increasing demand for orthopaedic, cardiovascular, and dental implants has driven growth across the market. Regulatory approvals and higher healthcare spending have likely supported this trend.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76047356
Europe accounts for the second-largest share in the medical coating market in terms of value.
Europe holds the second-largest share by value in the medical coating market, after North America, thanks to the region's well-developed healthcare infrastructure and large medical device manufacturing base. The region is characterized by strict regulatory environments like the EU Medical Device Regulation (MDR) and a strong focus on infection prevention, control, and AM coatings. Countries such as Germany, France, and the United Kingdom are the main demand drivers for coated devices, especially those related to cardiovascular and orthopaedic applications. Additionally, rising healthcare expenditures and the rapid expansion of wearable technologies are boosting the industry's growth across Europe.
Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=76047356
Key Players
Acquisitions and expansions serve as the main growth strategies used by leading companies in the market. The major global players in the medical coating industry include Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US), and The Sherwin-Williams Company (US).
Get access to the latest updates on Medical Coating Companies and Medical Coating Market Size
Browse Adjacent Market: Coatings Adhesives Sealants & Elastomers Research Reports & Consulting
Related Reports:
Antimicrobial Coatings Market - Global Forecast to 2027
Thermal Spray Coatings Market - Global Forecast to 2028
Textile Coatings Market - Global Forecast to 2028
ETFE & ECTFE Coatings Market - Global Forecast to 2030
Industrial Coatings Market - Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comVisit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/medical-coating-market-worth-15-813-6-million-by-2030---exclusive-report-by-marketsandmarkets-302510468.html
SOURCE MarketsandMarkets
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Tariffs Cloud General Motors' Outlook As Annual Profits Remain At Risk
General Motors Company (NYSE:GM) is navigating a complex automotive landscape, contending with rising tariffs and significant capital expenditures, yet the company remains steadfast in its projection of $7.5 billion to $10 billion in free cash flow for 2025. Despite a mixed second quarter, marked by a sharp drop in the company's adjusted EBIT margins to 6.4% and a substantial $1.1 billion tariff headwind, the auto giant still surpassed revenue and earnings expectations. However, the company anticipates a challenging second half, particularly in North America, with expected declines in wholesale volumes and increased tariff burdens, though strategic measures are in place to mitigate these this backdrop, Bank Of America Securities analyst Federico Merendi reiterated the Buy rating on General Motors, lowering the price forecast from $65 to $62. The auto behemoth registered second-quarter adjusted earnings per share of $2.53, beating the analyst consensus estimate of $2.40. Quarterly sales of $47.12 billion outpaced the Street view of $45.57 billion. Merendi highlights that China operations have now delivered two consecutive profitable quarters. He adds that the company kept its full‑year guidance intact but cautioned that adjusted EBIT in the back half is likely to trail first‑half results, driven by a mid‑single‑digit sequential drop in North American wholesale volumes, translating to roughly an 8% year‑over‑year decline in the second half of 2025. Merendi also points out that, unlike earlier messaging, the third quarter will carry a heavier gross tariff burden than the second quarter, though mitigating actions should soften the impact, and that stronger free cash flow in the second half could pave the way for share buybacks. Looking toward year‑end, the analyst sees a tougher fourth quarter, with North America deliveries down about 9% and margin pressure, while noting that favorable mix shifts and further improvements in China should help offset some of those headwinds. The analyst notes that while higher capital expenditures aren't ideal, General Motors' peers face the same challenge, making the relative impact more manageable. General Motors still expects to generate $7.5 billion to $10 billion of adjusted free cash flow in 2025, providing flexibility for both shareholder returns and reinvestment in the business. Price Action: GM shares are trading higher by 8.79% to $53.19 at last check Wednesday. Read Next:Photo by Jonathan Weiss via Shutterstock Latest Ratings for GM Date Firm Action From To Mar 2022 Benchmark Maintains Buy Feb 2022 Nomura Instinet Downgrades Buy Neutral Feb 2022 Morgan Stanley Downgrades Overweight Equal-Weight View More Analyst Ratings for GM View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? GENERAL MOTORS (GM): Free Stock Analysis Report This article Tariffs Cloud General Motors' Outlook As Annual Profits Remain At Risk originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
4 minutes ago
- Yahoo
Commanders' Bobby Wagner joins WNBA ownership group
Washington Commanders linebacker Bobby Wagner did something this week that no other active NFL player has done: He joined the ownership group for WBNA's Seattle Storm. The only other NFL player to have an ownership stake in a WNBA team is retired quarterback Tom Brady, who has an ownership stake in the Las Vegas Aces. Wagner was drafted by the Seattle Seahawks, where he played 10 consecutive seasons. 'Bobby is a hometown hero who has had immeasurable impact on the Seattle community,' said Seattle Storm Co-Owner Lisa Brummel. 'He shares our desire to grow the game and knows the value and importance of investing in women's sports. As we continue to build on the incredible legacy of the Storm franchise, we are excited to add Bobby's experience and expertise to the mix.' 'It's an honor to join the Seattle Storm ownership group and support a franchise that has consistently set the standard in women's professional sports,' said Wagner. 'This is about more than basketball, it's about investing in a legacy of excellence, empowering women, and continuing to elevate the game for future generations.' Wagner says that Kobe Bryant's legacy was an influence in his decision to join the ownership group, continuing to promote women's sports, and Commanders' minority owner Magic Johnson for his mentorship. Now entering his 14th season in the league, Wagner may be on the East Coast, but he's certainly not forgetting his West Coast roots. And to purchase a stake in a women's professional sport to help elevate women's sports is truly inspirational. The interest in the WNBA continues to rise, and with guys like Wagner supporting them, little girls everywhere have role models to look up to and aspire to be like. This article originally appeared on Commanders Wire: Commanders' Bobby Wagner joins Seattle Storm ownership group
Yahoo
4 minutes ago
- Yahoo
Why Chubb Stock Wilted on Wednesday
Key Points The company did well in its second quarter, but it suffers from being in an unpopular category. Many market players are disinterested in "defensive" stocks just now. 10 stocks we like better than Chubb › Chubb (NYSE: CB) stock seemed to be primed for a good Wednesday on the market after it reported quarterly results, however, investors had other plans for the storied insurance company. While it beat analyst estimates for its latest quarter, some of its fundamentals raised concerns. As a result they collectively traded out of the stock, leaving it with a more than 4% loss in price on the day around 3 p.m. ET. Negative reaction to positive developments After market hours Tuesday, Chubb published its second-quarter results. These revealed that the company's net premiums written -- considered something of a top-line metric by insurance sector investors -- rose by 6% year-over-year to just shy of $14.2 billion. Net income was slightly under $3 billion, up from the year-ago quarter's $2.2 billion. The company's "core operating income," i.e. under non-GAAP (adjusted) standards, rose to $6.14 per-share from the year-ago profit of $5.38. On average, analysts tracking Chubb stock were estimating the company would book revenue of $14.16 billion, and core operating income of $5.96 per share. In its earnings press release, management attributed the improvements to strength in various markets. It quoted CEO Evan Greenberg as saying that "most all of our businesses and regions of the world contributed to record quarterly results, illustrating the distinctive, diversified nature of our company." The trend is against it The market's reaction to Chubb's generally fine quarter likely had more to do with external factors than dissatisfaction with the company. Many investors are turning away from defensive stocks these days, and that includes sturdy insurance titles like Chubb. In such an environmentm the company probably needed to deliver a spectacular quarter, rather than one that was "merely" above average in order to impress investors. Should you invest $1,000 in Chubb right now? Before you buy stock in Chubb, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Chubb wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $641,800!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,023,813!* Now, it's worth noting Stock Advisor's total average return is 1,034% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Chubb Stock Wilted on Wednesday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
